Annexin Pharmaceuticals AB (publ) (ANNX.ST)
SEK 0.43
(-1.61%)
SEK 0.43
(-1.61%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -43.4 Million | -41.16 Million | -45.02 Million | -39.19 Million | -25.72 Million | -28.5 Million |
| Net Income | -44.05 Million | -40.72 Million | -51.23 Million | -43.73 Million | -28.32 Million | -28.7 Million |
| Depreciation & Amortization | 193 Thousand | 193 Thousand | 192 Thousand | 193 Thousand | 193 Thousand | 193 Thousand |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 458 Thousand | -632 Thousand | 1.73 Million | 569 Thousand | -1.58 Million | 150 Thousand |
| Other non-cash items | -611 Thousand | -2000.00 | 4.28 Million | 3.77 Million | 3.99 Million | 46 Thousand |
| Investing Cash Flow | 96 Thousand | -260 Thousand | - | -96 Thousand | - | -50 Thousand |
| Investments in PPE | 43.4 Million | - | - | - | - | -50 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | -260 Thousand | - | -96 Thousand | - | - |
| Sales/Maturities of investments | 96 Thousand | - | - | - | - | - |
| Other Investing Activities | 96.00 | -260.00 | - | -96.00 | - | -50.00 |
| Financing Cash Flow | 33.6 Million | 23.06 Million | 76.37 Million | 53.16 Million | -229 Thousand | 44 Million |
| Debt repayment | - | - | -20 Million | -4.22 Million | -229 Thousand | -250 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 33.6 Million | 23.1 Million | 66.66 Million | 61 Million | - | 51.87 Million |
| Other Financing Activities | 33.6 Thousand | -47 Thousand | 29.7 Million | -3.61 Million | -229.00 | -7.61 Million |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | 997 Thousand | -182 Thousand | 611 Thousand | 492 Thousand | -713 Thousand | 320 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | -539 Thousand | -450 Thousand | 1.12 Million | 77 Thousand | -875 Thousand | -170 Thousand |
| Cash at beginning of period | 31.11 Million | 49.47 Million | 18.13 Million | 4.26 Million | 30.21 Million | 14.76 Million |
| Cash at end of period | 21.41 Million | 31.11 Million | 49.47 Million | 18.13 Million | 4.26 Million | 30.21 Million |
| Capital Expenditure | 43.4 Million | - | - | - | - | -50 Thousand |
| Effect of forex changes on cash | -1000.00 | - | - | - | - | - |
| Net cash flow / Change in cash | -9.69 Million | -18.36 Million | 31.34 Million | 13.86 Million | -25.95 Million | 15.45 Million |
| Free Cash Flow | - | -41.16 Million | -45.02 Million | -39.19 Million | -25.72 Million | -28.55 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -10.92 Million | -14.51 Million | -12.45 Million | -44.05 Million | -14.54 Million | -10.72 Million |
| Depreciation & Amortization | - | 48.00 | 48 Thousand | 193 Thousand | 48 Thousand | 48 Thousand |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -808 Thousand | -257 Thousand | -1.12 Million | 458 Thousand | 1.88 Million | -187 Thousand |
| Other non-cash items | 48 Thousand | -1.68 Million | -1000.00 | -611 Thousand | -1.85 Million | -113 Thousand |
| Investing Cash Flow | - | - | - | 96 Thousand | - | - |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | 96 Thousand | - | - |
| Other Investing Activities | - | - | - | 96.00 | - | - |
| Financing Cash Flow | -24 Thousand | 44.2 Million | -10 Thousand | 33.6 Million | 22.72 Million | 5 Million |
| Debt repayment | - | - | - | - | -10 Million | -5 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | 44.2 Million | -10 Thousand | 33.6 Million | 32.72 Million | - |
| Other Financing Activities | -24 Thousand | 10 Thousand | -10.00 | 33.6 Thousand | 1.00 | 10 Million |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | - | 1.73 Million | -2.33 Million | 997 Thousand | 1.95 Million | -1.04 Million |
| Inventory | - | - | - | - | - | - |
| Other working capital | -808 Thousand | -1.99 Million | 1.2 Million | -539 Thousand | -73 Thousand | 853.99 Thousand |
| Cash at beginning of period | 37.35 Million | 7.87 Million | 21.41 Million | 31.11 Million | 11.3 Million | 17.28 Million |
| Cash at end of period | 25.64 Million | 37.35 Million | 7.87 Million | 21.41 Million | 21.41 Million | 11.3 Million |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | - | - | - | -1000.00 | - | - |
| Net cash flow / Change in cash | -11.71 Million | 29.48 Million | -13.54 Million | -9.69 Million | 10.11 Million | -5.97 Million |
| Free Cash Flow | -11.68 Million | -14.72 Million | -13.53 Million | -43.4 Million | -12.61 Million | -10.97 Million |
ALLR
TRAD
PREC
SAI
SYNACT
RAIL